Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Santosh L. Vishwakarma"'
Autor:
Dinesh Thiagaraj, Sridharan Rajagopal, Rudresh G, Prasanthi Daram, Mohd Zainuddin, Naveen Sadhu, Chandru G, Amir Siddiqui, Neha Ks, Basava Prabhu, Subramanyam J Tantry, Santosh L. Vishwakarma, Saif wahid, Sreekala Nair, Krishnakumar, Sivanandhan Dhanalakshmi
Publikováno v:
Blood. 136:29-29
Introduction: Lysine specific demethylase 1 (LSD1) and histone deacetylases (HDACs) are known to modulate the expression of several disease specific genes as part of repressor complexes, including CoREST. In addition, they also have complex mutually
Autor:
Santosh L. Vishwakarma, G Vijaykant, Pranesha Shetty, Shridhar Narayanan, Uma Maheswari Krishnan, J. Raghul, Nagaraj M. Kulkarni, Yeshwant Kurhe, Shilpee Chaudhary, Jeyamurugan Mookkan, Mallikarjun S Jaji, B Navin Rajesh
Publikováno v:
Pharmaceutical Biology. 53:1110-1117
Metabolic syndrome and non-alcoholic fatty liver disease (NAFLD) are the emerging co-morbidities of skin inflammation. Occurrence of skin inflammation such as psoriasis is substantially higher in NAFLD patients than normal. Currently, there are no an
Autor:
Ganapavarapu Veera Ragh Sharma, Sanjeev Saxena, Narasimhan Kilambi, Lavanya Andiappan, C.V. Srinivasan, Gopalan Balasubramanian, Saravanakumar Natarajan, Shridhar Narayanan, Santosh L. Vishwakarma, Fakrudeen Ali Ahamed Nazumudeen, Thirunavukkarasu Sappanimuthu, Sukunath Narayanan, Sridharan Rajagopal, Saravanan Thirunavukkarasu, Shamundeeswari Sundaram, Naresh Sivaraman
Publikováno v:
Bioorganicmedicinal chemistry. 24(22)
Herein we report the synthesis, PDE-4B and TNF-α inhibitory activities of a few dibenzo[b,d]furan-1-yl-thiazole derivatives. The hydroxycyclohexanol amide derivatives 14, 18, 24, 29, 31 and 33 exhibited promising in vitro PDE-4B and TNF-α inhibitor
Autor:
Anjana A. Adhyapak, Suraj Tubachi, Vijay Benade, Vijay Hebballi, Santosh L. Vishwakarma, Nagaraj M. Kulkarni, Saudagar Mohammad Ashfaque, B.S. Thippeswamy, Farhin R. Khan, Mahamad Yunnus A. Mahat, Basangouda M. Patil
Publikováno v:
European Journal of Pharmacology. 642:169-176
Kaempferol has been reported to inhibit nitric oxide synthase and cyclooxygenase enzymes in animal models. The present study was designed to investigate whether kaempferol modulates the cyclooxygenase pathway via inhibition of nitric oxide production
Publikováno v:
Journal of Planar Chromatography – Modern TLC. 17:128-131
Swertiamarin is a secoiridoid glucoside present in members of the Gentianaceae family, including Swertia chirata (Wall) Clarke, S. japonica Makino, S. angustifolia Buch.-Ham.ex D. Don, and Enicostemma littorale Blume. It has antidepressant and antich
Publikováno v:
Journal of Pharmacy and Pharmacology. 56:101-105
The fresh and dried rhizome of Zingiber officinale Roscoe (commonly known as ginger) is widely used in traditional medicine. We have studied the effect of the juice of Z. officinale (4 mL kg−1, p.o. daily) for 6 weeks on streptozotocin (STZ)-induce
Publikováno v:
Pharmaceutical Biology. 42:400-403
We report a simple method for the isolation of swertiamarin, a secoiridoid glycoside, from the whole plant of Enicostemma littorale Blume. Methanol extract of defatted plant material when treated with diethyl ether gave a precipitate containing swert
Publikováno v:
Oriental Pharmacy and Experimental Medicine. 3:196-204
Aqueous extract of Enicostemma littorale is reported to have antidiabetic activity. In the present investigation, we studied the effect of aqueous extract of E. littorale and its different fractions i.e., toluene, chloroform, ethyl acetate, n-butanol
Autor:
G. Vijaykanth, Uma Maheswari Krishnan, J. Raghul, Santosh L. Vishwakarma, Nagaraj M. Kulkarni, Milind M. Muley, Neetin Kumar D. Reddy, Jeyamurugan Mookkan, Navin B. Rajesh, Shridhar Narayanan, Mallikarjun S Jaji
Publikováno v:
Archives of pharmacal research. 38(6)
Atorvastatin is a 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitor used in the treatment of atherosclerosis and dyslipidemia. Studies have evaluated the utility of statins in the treatment of skin inflammation but with varied results. In the
Autor:
Shridhar Narayanan, Arun Shastry, Santosh L. Vishwakarma, Jayanarayan Kulathingal, J. Raghul, Virendra Kachhadia, Navin B. Rajesh, Sridharan Rajgopal, Milind M. Muley, Gopalan Balasubramanian, Narasimhan Kilambi, Ambrish Saxena, G. Vijaykanth, Pankaj Singh, Suresh Rathinasamy, Lakshmi R. Iyer
Publikováno v:
International immunopharmacology. 16(1)
Epigenetic modifications represent a promising new approach to modulate cell functions as observed in autoimmune diseases. Emerging evidence suggests the utility of HDAC inhibitors in the treatment of chronic immune and inflammatory disorders. Howeve